Ozagrel

From Wikipedia, the free encyclopedia

Ozagrel

Systematic (IUPAC) name
(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ Prescription only
Routes	Oral
Identifiers
CAS number	82571-53-7^Y
ATC code	None
PubChem	CID 5282440
UNII	L256JB984D^N
KEGG	D08327^Y
ChEMBL	CHEMBL11662^N
Chemical data
Formula	C₁₃H₁₂N₂O₂
Mol. mass	228.24 g/mol
SMILES C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O
N (what is this?) (verify)

Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.^[1]

References

↑ Loo MH, Egan D, Vaughan ED, Marion D, Felsen D, Weisman S (March 1987). "The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction". J. Urol. 137 (3): 571–6. PMID 3820396.

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.